CERUS CORP
CERS · NASDAQ
Updated at 2026-10-15 06:44:56
- Today's High
- $2.25
- Today’s Low
- $2.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.23
- Previous Close
- $2.24
- Volume
- 2.89M
- Market Cap
- $451.41M
- P/E Ratio
- --
- EPS
- $-0.03
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- 1220 CONCORD AVENUE, CONCORD, CA, UNITED STATES, 94520
- Country
- US
- Listing Date
- 1997-01-31
- Fiscal Year End
- December
- Shares Outstanding
- 200.37M
- CIK
- 0001020214
- Website
- www.cerus.com
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.
Financial Metrics
Revenue
2026-06-30
$57.44M
2026-03-31
$53.66M
2025-12-31
$57.75M
2025-09-30
$52.69M
Operating Expenses
2026-06-30
$31.39M
2026-03-31
$28.24M
2025-12-31
$30.39M
2025-09-30
$26.9M
Net Income
2026-06-30
-$2.94M
2026-03-31
-$1.64M
2025-12-31
-$2.18M
2025-09-30
-$19K
Net Profit Margin
2026-06-30
-5.11%
2026-03-31
-3.05%
2025-12-31
-3.78%
2025-09-30
-0.03%
Earnings Per Share
2026-06-30
$-0.01
2026-03-31
$-0.01
2025-12-31
$-0.01
2025-09-30
$0.00
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$712K
2026-03-31
$762K
2025-12-31
$292K
2025-09-30
$2.56M
Effective Tax Rate
2026-06-30
-3.29%
2026-03-31
-5.84%
2025-12-31
-5.76%
2025-09-30
130.76%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $57.44M | $53.66M | $57.75M | $52.69M |
| Operating Expenses | $31.39M | $28.24M | $30.39M | $26.9M |
| Net Income | -$2.94M | -$1.64M | -$2.18M | -$19K |
| Net Profit Margin | -5.11% | -3.05% | -3.78% | -0.03% |
| Earnings Per Share | $-0.01 | $-0.01 | $-0.01 | $0.00 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$712K | $762K | $292K | $2.56M |
| Effective Tax Rate | -3.29% | -5.84% | -5.76% | 130.76% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.